Breast Cancer Clinical Trial

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Summary

The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

View Full Description

Full Description

This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber Cancer Institute.

The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching.

Participants will be randomized into one of two groups.

Usual Care or Usual Care with customized resource matching.

It is expected that about 125 participants will take part in this research study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate.

Group A

BIPOC (Black, Latinx, Native American or Pacific Islander)
LEP Spanish-speaking (As indicated by the EHR)
Low SES (from zip code with median household income <$32,000/year) OR
Age 70+

Group B

Any one NPIQ response indicating SDoH need
Health literacy/numeracy, Caregiving/relationships, OR Finances

Exclusion Criteria:

- Group A and B

-- Patients not continuing care at Dana Farber Cancer Institute

Study is for people with:

Breast Cancer

Estimated Enrollment:

125

Study ID:

NCT04879927

Recruitment Status:

Recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02215, United States More Info
Nadine J. McCleary, MD, MPH
Contact
617-632-6729
[email protected]
Nadine J. McCleary, MD, MPH
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

125

Study ID:

NCT04879927

Recruitment Status:

Recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.